Drug Shortage Report for DILAUDID
| Report ID | 176092 |
| Drug Identification Number | 00705438 |
| Brand name | DILAUDID |
| Common or Proper name | Hydromorphone hydrochloride |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2022-11-24 |
| Actual start date | 2022-11-24 |
| Estimated end date | 2023-01-13 |
| Actual end date | 2023-01-11 |
| Shortage status | Resolved |
| Updated date | 2023-01-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-11-28 | English | Compare |